Regulatory & Legal

As biotech firm Seer secures key patent wins, it's not just defending its tech—it's drawing the battle lines for the multi-billion dollar proteomics market.

A breakthrough melanoma test from SkylineDx has earned rare dual recognition, promising to reshape patient care by reducing unnecessary surgeries.

A lawsuit alleging a violent assault during a DoorDash alcohol delivery raises critical questions about gig platform liability and the hidden risks of convenience.

Tour operator Novaturas must pay a massive penalty after a court ruling on a COVID-era contract, highlighting the pandemic's lasting financial toll on the travel sector.

A lawsuit alleges top officials at the Mental Health Association of Nassau County sexually exploited, financially manipulated, and retaliated against a client.

A high-stakes lawsuit accuses the EU of supporting democratic erosion in Armenia, placing Brussels' foreign policy and geopolitical strategy under intense scrutiny.

A Chinese court cleared Biocytogen’s core antibody platform, a ruling that is less about one patent and more about validating a new era of sovereign innovation.

The high court's 7-2 decision on Roundup not only ends a legal saga for Bayer but signals a major shift in product liability across all federally regulated industries.

A lawsuit alleges a doctor was punished for prioritizing patient need over a VIP. The case exposes deep tensions in medical training, ethics, and leadership.

A bitter dispute between Solmate Infrastructure and its top investor, RockawayX, exposes deep governance flaws and the volatile intersection of finance and crypto.

Vaxart’s COVID pill vaccine trial sees funding cut, yet new funds for data analysis signal a complex bet by BARDA on the future of pandemic response.

A £1.3M debt dispute escalates as the National Bank of Uzbekistan pursues Solfy CA in English courts, alleging a smear campaign to derail justice.

Valgen Medtech's dual EU approval for its heart valve device isn't just a clinical win; it's a tremor in the global medical technology landscape.

CEA Industries reports a $115M profit, but a $130M crypto loss and a lawsuit against its own asset manager reveal the volatile reality of its BNB treasury.

An FDA fast-track for a devastating brain disease drug is a beacon of hope for patients and a major validation of Alphabet's long-term biotech strategy.

A record medical malpractice award in Maine is more than a legal victory; it's a harsh verdict on the systemic fractures in modern healthcare delivery.

Willie L. Jordan, who died at 93, transformed a Skid Row mission with a mother’s compassion, challenging the very definition of inner-city ministry.

As floods ravage the Southeast, U-Haul's pivot to mass relief reveals a new blueprint for corporate aid, turning commercial infrastructure into a critical lifeline.

Alberta is launching a controversial private healthcare option, promising efficiency. Critics warn it's a two-tier system that will let the rich jump the queue.

The junior miner's C$750k financing reveals a high-stakes play in a hot uranium market, balancing exploration ambition against significant investor dilution.